Picture of Eckert & Ziegler Strahlen und Medizintechnik AG logo

EUZ Eckert & Ziegler Strahlen und Medizintechnik AG Share Price

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Momentum

Relative Strength (%)
1m+6.85%
3m+20.93%
6m-10.38%
1yr-33.21%
Volume Change (%)
10d/3m-10.11%
Price vs... (%)
52w High-34%
50d MA+11.5%
200d MA-3.33%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)25.21
PEG Ratio (f)1.08
EPS Growth (f)30.52%
Dividend Yield (f)1.28%
Valuation (ttm)IndustryMarket
Price to Book Value3.63
Price to Tang. Book6.63
Price to Free Cashflow73.38
Price to Sales3.35
EV to EBITDA14.77

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital11.15%
Return on Equity12.43%
Operating Margin16.73%

Financial Summary

Year End 31st DecUnit201820192020202120222023E2024ECAGR / Avg
Total Revenue€m168.71178.49176.14180.44222.26240264.69.9%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+55.97+49.81-13.21+26.94+14.51-6.77+34.89n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Eckert & Ziegler Strahlen und Medizintechnik AG EPS forecast chart

Profile Summary

Eckert & Ziegler Strahlen und Medizintechnik AG is a Germany-based provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

Directors

Last Annual
December 31st, 2022
Last Interim
September 30th, 2023
Incorporated
December 10th, 1997
Public Since
February 25th, 2008
No. of Employees
1,062
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
de flag iconXETRA
Shares in Issue
20,812,426
Blurred out image of a map
Address
Robert-Roessle-Str.10, BERLIN, 13125
Web
https://www.ezag.com/
Phone
+49 309410840
Contact
Karolin Riehle
Auditors
BDO AG Wirtschaftsprufungsgesellschaft

EUZ Share Price Performance

Upcoming Events for EUZ

Q4 2023 Eckert & Ziegler Strahlen und Medizintechnik AG Earnings Release

Q1 2024 Eckert & Ziegler Strahlen und Medizintechnik AG Earnings Release

FAQ

Or unlock with your email

Or unlock with your email